ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,264.28
-0.25%
Dow Jones
38,465.26
-0.57%
US Dollar vs MXN
17.50896
3.14%
Brent Oil
78.535
-2.81%
Bitcoin
68,974.79
1.79%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX
  6. Aeon Metals Limited (AMLN)

  7. Aeon Metals Limited (AMLN) Noticias

AMLN

Aeon Metals (AMLN)

Aeon Metals Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:ASX:AMLN
FechaHoraFuenteTítuloSímboloCompañía
29/10/200907:34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
29/10/200904:02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200916:21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200915:17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200915:05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/09/200905:16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/08/200907:28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/07/200916:20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200906:01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200905:06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSONASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200905:30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200902:13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200902:12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200902:12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200919:00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200914:22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200912:59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200912:36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200915:37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200915:05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/05/200914:02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateNASDAQ:AMLNAmylin Pharmaceuticals Inc.
18/05/200907:17Dow Jones NewsMore Proxy Advisers Back Dissidents' Amylin Board NomineesNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200917:24Dow Jones NewsUPDATE: Risk Metrics Backs Three Dissident Amylin DirectorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200916:53Dow Jones NewsRisk Metrics Backs Three Dissident Directors For Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
14/05/200910:13Dow Jones NewsUPDATE: Icahn Fires Back At Amylin Over Latest LetterNASDAQ:AMLNAmylin Pharmaceuticals Inc.
04/05/200916:29Dow Jones NewsAmylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10NASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/04/200913:55Dow Jones NewsDEALWATCH: Lilly Can't Afford To Double Down With AmylinNASDAQ:AMLNAmylin Pharmaceuticals Inc.
28/04/200915:03Dow Jones NewsAmylin Proxy Battle Adds To Debate Over What Makes A 'Group'NASDAQ:AMLNAmylin Pharmaceuticals Inc.
24/04/200904:47Dow Jones NewsUPDATE: Novo Nordisk Has Big Hopes For EU Victoza LaunchNASDAQ:AMLNAmylin Pharmaceuticals Inc.
20/04/200914:01Dow Jones NewsUPDATE: US Drug Stocks Flee Into Negative TerritoryNASDAQ:AMLNAmylin Pharmaceuticals Inc.
 Showing the most relevant articles for your search:ASX:AMLN

Su Consulta Reciente

LSE
CLIO
Cape Lambert Iron Ore
LSE
63QQ
City Stock. 25
BOV
AURA33Q
Aura Minerals
TSX
BTCX.B
CI Galaxy Bitcoin ETF
BIT
P1QL09
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados